OBIO, through its Life Sciences Critical Technology and Commercialization (LSCTC) Centre for Excellence, is supporting the adoption of the Extubation Advisor (EA) at The Ottawa Hospital (TOH). Developed by Canadian company Therapeutic Monitoring Systems Inc. (TMS), this AI-powered clinical support tool is designed to assist clinicians in making extubation decisions in intensive care units.
The EA was adopted after successful evaluations were completed at TOH and Unity Health through OBIO’s Early Adopter Health Network program. EAHN is supported by the Government of Canada, through the Federal Economic Development Agency for Southern Ontario , and LSCTC is supported by the Government of Ontario.
Removing a patient from mechanical ventilation, which is known as extubation, is a complex process in critical care. The EA, based on research led by Dr. Andrew JE Seely, a thoracic surgeon and Intensive Care Unit (ICU) physician at TOH and CEO of TMS, uses AI to analyze patient-specific respiratory data and help clinicians with extubation decision making. This reduces uncertainty by identifying patients at higher or lower risk of extubation failure, leading to better patient outcomes and more efficient use of ICU resources.
“This tool represents more than a decade of research into how patient data can guide better care,” said Dr. Seely, CEO of Therapeutic Monitoring Systems Inc. (TMS) and Chief of Thoracic Surgery at TOH. “Extubation decisions are some of the most difficult ones we make in the ICU, and the Extubation Advisor gives clinicians access to real-time, evidence-based predictions to help guide those moments. We’re grateful to OBIO for helping translate research into practice in a way that has the potential to benefit patients across Canada and internationally.”
Health Technology Insights: Wolters Kluwer Launches Ovid Synthesis Expert AI
TOH is one of the first hospitals to implement the EA as part of a real-world evaluation. The technology complements existing clinical judgment by offering personalized, data-driven insights that may help reduce ICU stays and minimize complications related to ventilation.
“The Ottawa Hospital continues to lead in medical innovation, and the Extubation Advisor is a strong example of how we are using technology to enhance care in the ICU,” said Dr. Kwadwo Kyeremanteng, Chair of Critical Care at The Ottawa Hospital. “By supporting more informed and individualized decisions, this tool has the potential to improve patient outcomes and make our system more efficient.”
Health Technology Insights: Hippocratic AI Selects Fivetran to Power Trusted Data Infrastructure for AI in Healthcare
The EA has received regulatory clearance from both Health Canada and the European Union. TMS is now working with additional healthcare partners in Canada and internationally to expand and broadly adopt its use.
“This partnership with The Ottawa Hospital and Therapeutic Monitoring Systems is a powerful demonstration of how made-in-Ontario AI-powered tools can be successfully integrated into critical care to improve patient outcomes,” said Dr. Maura Campbell, President and CEO of OBIO. “Through our EAHN™ and LSCTC programs, we are proud to have supported the evaluation and adoption of the Extubation Advisor, showcasing our commitment to translating cutting-edge research into real-world healthcare solutions that enhance clinical decision-making and make our hospital systems more efficient.”
“Congratulations to OBIO, The Ottawa Hospital, and Therapeutic Monitoring Systems on this important milestone,” said the Honourable Evan Solomon, Minister of Artificial Intelligence and Digital Innovation and Minister responsible for the Federal Economic Development Agency for Southern Ontario. “The Extubation Advisor is a Canadian-made, AI-powered technology that is improving patient care. Our government will continue to support partnerships that translate research into real-world solutions, ensuring Canada remains a leader in health innovation.”
Health Technology Insights: Cardiosense Shows AI Heart Failure Data at Transcatheter Cardiovascular Therapeutics 2025
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
